Early loss of endogenous NAD <sup>+</sup> following rotenone treatment leads to Sarm1 activation that is ameliorated by PARP inhibition
Ankita Sarkar(Indian Institute of Technology Mandi), Piyali Mukherjee(National Institutes of Health)
Cited by 2
Related Papers
Butyrate limits inflammatory macrophage niche in NASH
|Cell Death and Disease|2023|88
SARM1, Not MyD88, Mediates TLR7/TLR9-Induced Apoptosis in Neurons
|The Journal of Immunology|2015|67
Cationic dextrin nanoparticles for effective intracellular delivery of cytochrome <i>C</i> in cancer therapy
|RSC Chemical Biology|2023|6